PPARγ is dispensable for clear cell renal cell carcinoma progression

OBJECTIVE: Clear cell renal cell carcinoma (ccRCC) is a subtype of kidney cancer defined by robust lipid accumulation, which prior studies have indicated plays an important role in tumor progression. We hypothesized that the peroxisome proliferator-activated receptor gamma (PPARγ), detected in both...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez, Danielle J., Steger, David J., Skuli, Nicolas, Bansal, Ankita, Simon, M. Celeste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034040/
https://www.ncbi.nlm.nih.gov/pubmed/29866440
http://dx.doi.org/10.1016/j.molmet.2018.05.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034040/
https://www.ncbi.nlm.nih.gov/pubmed/29866440
http://dx.doi.org/10.1016/j.molmet.2018.05.013

Ejemplares similares